Your browser doesn't support javascript.
loading
Liuwei Dihuang Pill inhibits mitogen-activated protein kinase signaling cascade of nucleus pulposus cells in a model of intervertebral disc degeneration / 中国组织工程研究
Article en Zh | WPRIM | ID: wpr-513547
Biblioteca responsable: WPRO
ABSTRACT
BACKGROUND:JNKs and p38 MAPK, as important members of mitogen-activated protein kinase (MAPK), play critical roles in the cell proliferation, differentiation, transformation and apoptosis. OBJECTIVE:To observe the effects of Liuwei Dihuang Pill on the MAPK signaling cascade of nucleus pulposus cells in a rabbit model of intervertebral disc degeneration. METHODS:100 discs samples with endplate cartilages were equivalently randomized into five groups and cultured in the medium containing 10 mg/L tumor necrosis factor-α(TNF-α, 2μL), p38-JNK/SAPK blockers (10μL of 20μmol/L SB203580 and SP600125, 2μL of 10μmol/L TNF-α), 10%Liuwei Dihuang Pill serum, 10 mg/L TNF-α(2μL) plus 10%Liuwei Dihuang Pill serum, respectively. Those cells received no intervention as controls. Samples were collected and detected at 2, 4, 8 and 14 days of culture. RESULTS AND CONCLUSION:Real time-PCR and western blot assay showed that mRNA and protein expressions of JNK and P38 pathways by the nucleus pulposus cells were upregulated with time, while all above indicators were significantly decreased by the Liuwei Dihuang Pill serum. These findings reveal that Liuwei Dihuang Pill can delay the process of disc degeneration by blocking JNK and P38 signaling pathways, thus exerting protective effect on the intervertebral discs.
Texto completo: 1 Base de datos: WPRIM Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: Zh Revista: Chinese Journal of Tissue Engineering Research Año: 2017 Tipo del documento: Article
Texto completo: 1 Base de datos: WPRIM Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: Zh Revista: Chinese Journal of Tissue Engineering Research Año: 2017 Tipo del documento: Article